The absolute reversal of glucose intolerance, IR, dyslipidemia and perturbations in the host as well as in microbial derived metabolites in iNOS-/- mice with ampicillin-neomycin intervention establish that gut bacteria are crucial drivers of the metabolic phenotype in these mice. The gene discussed is NOS2; the disease is metabolic syndrome.